Public Profile

Almirall

Almirall, S.A., a prominent global pharmaceutical company headquartered in Barcelona, Spain, has established itself as a leader in the dermatology and respiratory sectors since its founding in 1943. With a strong presence across Europe and the United States, Almirall focuses on developing innovative treatments that address unmet medical needs. The company’s core offerings include prescription medications and advanced therapies, particularly in dermatology, where it is renowned for its unique formulations and patient-centric approach. Almirall has achieved significant milestones, including strategic partnerships and a robust pipeline of products that enhance its market position. Recognised for its commitment to research and development, Almirall continues to make strides in improving patient outcomes and advancing healthcare solutions globally.

DitchCarbon Score

How does Almirall's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

27

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

13

Industry Benchmark

Almirall's score of 27 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.

92%

Almirall's reported carbon emissions

In 2022, Almirall S.A. reported total greenhouse gas emissions of approximately 404,000 kg CO2e for Scope 1 and 282,600 kg CO2e for Scope 2, resulting in a combined total of about 686,600 kg CO2e. This marks a significant reduction from 2021, where Scope 1 emissions alone were reported at 533,000,000 kg CO2e. Almirall has set ambitious climate commitments, aiming for net-zero greenhouse gas emissions across its entire value chain by 2050, using 2019 as the baseline year. The company has established near-term targets to reduce absolute Scope 1 and 2 emissions by 50% by 2030 and to achieve a 28% reduction in absolute Scope 3 emissions by the same year. Additionally, Almirall is committed to sourcing 100% renewable electricity annually through 2030. Long-term, Almirall aims for a 90% reduction in absolute emissions across all scopes (1, 2, and 3) by 2050. These targets align with industry standards and reflect the company's commitment to addressing climate change effectively.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

Add to project
20212022
Scope 1
533,000,000
000,000
Scope 2
-
000,000
Scope 3
-
-

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Almirall's primary industry is Medical, precision and optical instruments, watches and clocks (33), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Almirall is headquartered in ES, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Almirall is committed to some reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Other Organizations in Medical Device Manufacturing

Fiberguide Industries, Inc.

US
Medical Device Manufacturing
Updated 3 days ago

LJL BioSystems, Inc.

US
Medical Device Manufacturing
Updated 3 days ago

NAI Tech Products, Inc.

US
Medical Device Manufacturing
Updated 3 days ago

Tot Biopharm International Co

CN
Medical Device Manufacturing
Updated 10 days ago

Kelfred Optical Ltd.

GB
Medical Device Manufacturing
Updated 10 days ago

DIONEX Softron GmbH

DE
Medical Device Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers